세계의 동종 줄기세포 이식 시장 : 세포 유형별, 유래별, 용도별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Allogeneic Stem Cell Transplantation Market size was valued at USD 3,833.34 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

Allogeneic stem cell transplantation involves the transfer of healthy stem cells from a genetically compatible donor to the patient, replacing damaged cells. This established therapeutic technique is used to address various hematological cancers, blood disorders, and immunological conditions. Stem cells for allogeneic transplants can be sourced from peripheral blood, bone marrow, umbilical cord blood, or adipose tissue. The field has witnessed significant progress in harvesting methods, expansion protocols, cryopreservation, and cell processing.

Allogeneic Stem Cell Transplantation Market- Market Dynamics

Rising prevalence of hematologic malignancies and non-malignant disorders to propel market demand

The Allogeneic Stem Cell Transplantation Market is expected to witness substantial growth driven by the rising prevalence of hematologic malignancies and non-malignant disorders, where this transplantation method has shown promise. Additionally, increased investments in research and development, along with a robust pipeline of stem cell therapies, are anticipated to propel market expansion. The rising number of clinical trials exploring allogeneic stem cell transplantation across various therapeutic areas bodes well for future market growth. The increasing incidence of chronic diseases like cancer, autoimmune disorders, and blood ailments is a key driver for the allogeneic stem cell transplantation market. Cases of diseases such as leukemia, multiple myeloma, and lymphoma have steadily risen over the past decade. Allogeneic hematopoietic stem cell transplantation offers a potentially curative approach for many of these high-risk and drug-resistant hematological malignancies. According to the World Health Organization (WHO), cancer caused nearly 10 million deaths worldwide in 2020. The growing pool of patients and demand for advanced therapies to address these conditions will fuel market growth. Numerous research studies and clinical trials are underway to assess the safety and efficacy of allogeneic stem cell therapies for new applications beyond traditional blood cancers and disorders. Several phase 2 and 3 trials are investigating allogeneic stem cell therapies for conditions such as bone marrow fibrosis, osteoarthritis, stroke, traumatic brain injury, and myocarditis, among others. Robust pipeline activities aimed at expanding the treatment landscape will open up new avenues for market growth. For example, Novartis, a global pharmaceutical company, has initiated a phase 2 clinical trial using allogeneic stem cell transplantation to treat bone marrow fibrosis, with an expected completion date of October 2024.

Allogeneic Stem Cell Transplantation Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Source segmentation, Bone Marrow was predicted to show maximum market share in the year 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Allogeneic Stem Cell Transplantation Market- Segmentation Analysis:

The Global Allogeneic Stem Cell Transplantation Market is segmented on the basis of Cell Type, Source, Application, End User, and Region.

The market is divided into two categories based on Source: Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others. The bone marrow allogeneic stem cell transplantation market is poised to command a significant global market share in 2023. Bone marrow stem cell transplantation emerges as a promising therapeutic avenue for select hematological disorders, particularly in cases where conventional treatments have proven ineffective or disease recurrence has transpired. For eligible individuals, this treatment modality holds paramount importance as it offers the potential to extend life expectancy significantly, often free from relapse.

The market is divided into three categories based on End User: Hospitals, Research Institutes, Specialty Clinics, and Others. In 2023, the hospital end user segment predominantly contributes to allogeneic stem cell transplantation services, primarily owing to the sophisticated medical infrastructure available within modern hospitals. Notably, contemporary hospitals are equipped with cutting-edge medical technologies, including specialized units dedicated to bone marrow transplantation. These resources empower hospitals to deliver comprehensive pre- and post-transplant care to hematopoietic stem cell transplant (HSCT) recipients, particularly in regions such as the United States, Germany, the United Kingdom, China, and India.

Allogeneic Stem Cell Transplantation Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Allogeneic Stem Cell Transplantation Market- Competitive Landscape:

Companies and healthcare institutions are implementing strategic measures to enhance patient outcomes, foster innovation, and enhance access to transplantation services. A crucial aspect of this strategy involves continual advancements in transplant technologies and protocols through dedicated research and development endeavors. This encompasses investments in innovative prophylaxis methods for graft-versus-host disease (GVHD), refinement of conditioning regimens, and exploration of alternative stem cell sources to broaden eligibility criteria and enhance transplant success rates. Collaborations with academic institutions and research organizations play a vital role in validating and optimizing these advancements, ensuring their clinical applicability and effectiveness.

Recent Developments:

In September 2023, MaaT Pharma, a biotechnology company based in France, announced that the European Medicines Agency (EMA) has granted orphan drug designation to MaaT033. Developed by MaaT Pharma, MaaT033 is an adjunctive and maintenance therapy aimed at improving overall survival in Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Celgene Corporation

Mesoblast Ltd.

Pluristem Therapeutics Inc.

MEDIPOST Co., Ltd.

Osiris Therapeutics, Inc.

Cynata Therapeutics Limited

Takeda Pharmaceutical Company Limited

Astellas Pharma Inc.

Cellular Biomedicine Group, Inc.

Biosolution Co., Ltd.

StemCell Technologies Inc.

Caladrius Biosciences, Inc.

ViaCord

Vericel Corporation

Regen Biopharma Inc.

Gamida Cell Ltd.

Histogenics Corporation

BrainStorm Cell Therapeutics Inc.

Lineage Cell Therapeutics, Inc.

Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY CELL TYPE - MARKET ANALYSIS, 2019 - 2032

• Allogeneic MSCs
• Allogeneic HSCs
• Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

• Bone Marrow
• Peripheral Blood
• Umbilical Cord Blood
• Adipose Tissue
• Dental Pulp
• Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Cancer
• Autoimmune Diseases
• Blood Disorders
• Cardiac Disorders
• Neurological Disorders
• Diabetes
• Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Research Institutes
• Specialty Clinics
• Others

GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Allogeneic Stem Cell Transplantation Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Allogeneic Stem Cell Transplantation Market Snippet by Cell Type
  • 2.1.2.Allogeneic Stem Cell Transplantation Market Snippet by Source
  • 2.1.3.Allogeneic Stem Cell Transplantation Market Snippet by Application
  • 2.1.4.Allogeneic Stem Cell Transplantation Market Snippet by End User
  • 2.1.5.Allogeneic Stem Cell Transplantation Market Snippet by Country
  • 2.1.6.Allogeneic Stem Cell Transplantation Market Snippet by Region
• 2.2.Competitive Insights

3.Allogeneic Stem Cell Transplantation Key Market Trends

• 3.1.Allogeneic Stem Cell Transplantation Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Allogeneic Stem Cell Transplantation Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Allogeneic Stem Cell Transplantation Market Opportunities
• 3.4.Allogeneic Stem Cell Transplantation Market Future Trends

4.Allogeneic Stem Cell Transplantation Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Allogeneic Stem Cell Transplantation Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Allogeneic Stem Cell Transplantation Market Landscape

• 6.1.Allogeneic Stem Cell Transplantation Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Allogeneic Stem Cell Transplantation Market - By Cell Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
  • 7.1.2.Allogeneic MSCs
  • 7.1.3.Allogeneic HSCs
  • 7.1.4.Others

8.Allogeneic Stem Cell Transplantation Market - By Source

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Source, 2023 & 2032 (%)
  • 8.1.2.Bone Marrow
  • 8.1.3.Peripheral Blood
  • 8.1.4.Umbilical Cord Blood
  • 8.1.5.Adipose Tissue
  • 8.1.6.Dental Pulp
  • 8.1.7.Others

9.Allogeneic Stem Cell Transplantation Market - By Application

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2.Cancer
  • 9.1.3.Autoimmune Diseases
  • 9.1.4.Blood Disorders
  • 9.1.5.Cardiac Disorders
  • 9.1.6.Neurological Disorders
  • 9.1.7.Diabetes
  • 9.1.8.Others

10.Allogeneic Stem Cell Transplantation Market - By End User

• 10.1.Overview
  • 10.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
  • 10.1.2.Hospitals
  • 10.1.3.Research Institutes
  • 10.1.4.Specialty Clinics
  • 10.1.5.Others

11.Allogeneic Stem Cell Transplantation Market- By Geography

• 11.1.Introduction
  • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 11.2.North America
  • 11.2.1.Overview
  • 11.2.2.Allogeneic Stem Cell Transplantation Key Manufacturers in North America
  • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4.North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  • 11.2.5.North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.2.7.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.8.U.S.
    • 11.2.8.1.Overview
    • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3.U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4.U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.6.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.9.Canada
    • 11.2.9.1.Overview
    • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3.Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4.Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.6.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.3.Europe
  • 11.3.1.Overview
  • 11.3.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Europe
  • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4.Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  • 11.3.5.Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.7.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.8.Germany
    • 11.3.8.1.Overview
    • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3.Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4.Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.6.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.9.Italy
    • 11.3.9.1.Overview
    • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3.Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4.Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.6.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.10.United Kingdom
    • 11.3.10.1.Overview
    • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3.United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4.United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.6.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.11.France
    • 11.3.11.1.Overview
    • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3.France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4.France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.6.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.12.Russia
    • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.2.Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.12.3.Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.5.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.13.Netherlands
    • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.2.Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.13.3.Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.5.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.14.Sweden
    • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.2.Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.14.3.Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.5.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.15.Poland
    • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.2.Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.15.3.Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.5.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.16.Rest of Europe
    • 11.3.16.1.Overview
    • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.4.Asia Pacific (APAC)
  • 11.4.1.Overview
  • 11.4.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Asia Pacific
  • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4.Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  • 11.4.5.Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.7.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.8.India
    • 11.4.8.1.Overview
    • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3.India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4.India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.6.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.9.China
    • 11.4.9.1.Overview
    • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3.China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4.China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.6.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.10.Japan
    • 11.4.10.1.Overview
    • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3.Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4.Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.6.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.11.South Korea
    • 11.4.11.1.Overview
    • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3.South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4.South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.6.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.12.Australia
    • 11.4.12.1.Overview
    • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3.Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4.Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.6.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.13.Thailand
    • 11.4.13.1.Overview
    • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3.Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4.Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.6.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.14.Indonesia
    • 11.4.14.1.Overview
    • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3.Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4.Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.6.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.15.Philippines
    • 11.4.15.1.Overview
    • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3.Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4.Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.6.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.16.Rest of APAC
    • 11.4.16.1.Overview
    • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3.Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4.Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.6.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.5.Latin America
  • 11.5.1.Overview
  • 11.5.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Latin America
  • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4.Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  • 11.5.5.Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.7.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.8.Brazil
    • 11.5.8.1.Overview
    • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3.Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4.Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.6.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.9.Mexico
    • 11.5.9.1.Overview
    • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3.Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4.Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.6.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.10.Argentina
    • 11.5.10.1.Overview
    • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3.Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4.Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.6.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.11.Colombia
    • 11.5.11.1.Overview
    • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3.Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4.Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.6.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.12.Rest of LATAM
    • 11.5.12.1.Overview
    • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.6.Middle East and Africa
  • 11.6.1.Overview
  • 11.6.2.Allogeneic Stem Cell Transplantation Key Manufacturers in Middle East and Africa
  • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4.Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
  • 11.6.5.Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
  • 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.7.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.8.Saudi Arabia
    • 11.6.8.1.Overview
    • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.9.United Arab Emirates
    • 11.6.9.1.Overview
    • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.10.Israel
    • 11.6.10.1.Overview
    • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3.Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4.Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.6.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.11.Turkey
    • 11.6.11.1.Overview
    • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3.Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4.Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.6.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.12.Algeria
    • 11.6.12.1.Overview
    • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3.Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4.Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.6.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.13.Egypt
    • 11.6.13.1.Overview
    • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3.Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4.Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.6.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.14.Rest of MEA
    • 11.6.14.1.Overview
    • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3.Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4.Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.6.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Allogeneic Stem Cell Transplantation Industry

• 12.1.Competitive Dashboard
• 12.2.Company Profiles
  • 12.2.1.Celgene Corporation
  • 12.2.2.Mesoblast Ltd.
  • 12.2.3.Pluristem Therapeutics Inc.
  • 12.2.4.MEDIPOST Co., Ltd.
  • 12.2.5.Osiris Therapeutics, Inc.
  • 12.2.6.Cynata Therapeutics Limited
  • 12.2.7.Takeda Pharmaceutical Company Limited
  • 12.2.8.Astellas Pharma Inc.
  • 12.2.9.Cellular Biomedicine Group, Inc.
  • 12.2.10.Biosolution Co., Ltd.
  • 12.2.11.StemCell Technologies Inc.
  • 12.2.12.Caladrius Biosciences, Inc.
  • 12.2.13.ViaCord
  • 12.2.14.Vericel Corporation
  • 12.2.15.Regen Biopharma Inc.
  • 12.2.16.Gamida Cell Ltd.
  • 12.2.17.Histogenics Corporation
  • 12.2.18.BrainStorm Cell Therapeutics Inc.
  • 12.2.19.Lineage Cell Therapeutics, Inc.
  • 12.2.20.Others

13.360 Degree Analyst View

14.Appendix

• 14.1.Research Methodology
• 14.2.References
• 14.3.Abbreviations
• 14.4.Disclaimer
• 14.5.Contact Us